-caine
A local anaesthetic.
- Drugs ending in -caine: 18
- Approved somewhere: 11
- With a US drug page: 12
- Stem
- -caine
- Class
- Local anaesthetics that numb a small area
- Most common targets
- Sodium channel alpha subunit (13), SCN4A (2), SCN5A (1), SCN10A (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -caine, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Chloroprocaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Cocaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Dibucaine | Approved | SCN5A, SCN10A | Sodium channel protein type V alpha subunit blocker |
| Prilocaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Ropivacaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Tetracaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Articaine | Phase 3 | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Levobupivacaine | Phase 3 | SCN4A | Sodium channel protein type IV alpha subunit blocker |
| Mepivacaine | Phase 3 | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Proparacaine | Phase 3 | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Etidocaine | — | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Hexylcaine | — | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Benzocaine | Approved | — | Unknown |
| Bupivacaine | Approved | SCN4A | Sodium channel protein type IV alpha subunit blocker |
| Lidocaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Procaine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Procaine benzylpenicillin | Approved | — | Unknown |
| Propoxycaine | — | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO